Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2017 3
2018 6
2019 6
2020 17
2021 8
2022 11
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
Clinical implications of fetuin-A.
Jirak P, Stechemesser L, Moré E, Franzen M, Topf A, Mirna M, Paar V, Pistulli R, Kretzschmar D, Wernly B, Hoppe UC, Lichtenauer M, Salmhofer H. Jirak P, et al. Adv Clin Chem. 2019;89:79-130. doi: 10.1016/bs.acc.2018.12.003. Epub 2019 Feb 8. Adv Clin Chem. 2019. PMID: 30797472 Review.
How spaceflight challenges human cardiovascular health.
Jirak P, Mirna M, Rezar R, Motloch LJ, Lichtenauer M, Jordan J, Binneboessel S, Tank J, Limper U, Jung C. Jirak P, et al. Eur J Prev Cardiol. 2022 Aug 5;29(10):1399-1411. doi: 10.1093/eurjpc/zwac029. Eur J Prev Cardiol. 2022. PMID: 35148376 Review.
Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients.
Jirak P, Mirna M, Van Almsick V, Shomanova Z, Mahringer M, Lichtenauer M, Kopp K, Topf A, Sieg F, Kraus J, Gharibeh SX, Hoppe UC, Fiedler L, Larbig R, Pistulli R, Motloch LJ, Dieplinger AM. Jirak P, et al. J Pers Med. 2022 May 23;12(5):849. doi: 10.3390/jpm12050849. J Pers Med. 2022. PMID: 35629271 Free PMC article.
50 results